Another study by Mao et al29 suggested that OCT3/4 may promote tumor immune evasion in bladder cancer by enhancing the TET1–nuclear factor erythroid 2-related factor 2 (NRF2)–MDM2 pathway. The gene discussed is NFE2L2; the disease is urinary bladder carcinoma.